MTERF expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.061700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.803600E-01
Normal-vs-Stage2
8.389700E-02
Normal-vs-Stage3
1.279040E-01
Normal-vs-Stage4
9.776600E-01
Stage1-vs-Stage2
5.407200E-01
Stage1-vs-Stage3
1.015190E-01
Stage1-vs-Stage4
2.521400E-01
Stage2-vs-Stage3
1.944370E-01
Stage2-vs-Stage4
5.119700E-02
Stage3-vs-Stage4
3.843700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.012800E-01
Normal-vs-AfricanAmerican
2.657200E-01
Normal-vs-Asian
6.059000E-01
Caucasian-vs-AfricanAmerican
8.625800E-01
Caucasian-vs-Asian
5.707000E-01
AfricanAmerican-vs-Asian
6.453200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.034000E-02
Normal-vs-Female
1.220610E-01
Male-vs-Female
4.898800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.099200E-01
Normal-vs-Age(41-60Yrs)
5.266800E-01
Normal-vs-Age(61-80Yrs)
6.423800E-02
Normal-vs-Age(81-100Yrs)
1.436800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.409400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.451000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.513200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.898500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.818800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.888800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.070200E-02
Normal-vs-Daily Drinker
2.859600E-01
Normal-vs-Weekly Drinker
2.496200E-01
Normal-vs-Occasional Drinker
1.620390E-01
Normal-vs-Social Drinker
4.531400E-01
Non Drinker-vs-Daily Drinker
3.978800E-01
Non Drinker-vs-Weekly Drinker
4.340400E-01
Non Drinker-vs-Occasional Drinker
1.762150E-01
Non Drinker-vs-Social Drinker
1.006440E-01
Daily Drinker-vs-Weekly Drinker
1.765370E-01
Daily Drinker-vs-Occasional Drinker
3.678300E-02
Daily Drinker-vs-Social Drinker
1.168430E-02
Weekly Drinker-vs-Occasional Drinker
7.839600E-01
Weekly Drinker-vs-Social Drinker
8.446600E-01
Occasional Drinker-vs-Social Drinker
8.849200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.454200E-01
Normal-vs-Grade 2
5.891400E-01
Normal-vs-Grade 3
1.468580E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.288800E-01
Grade 1-vs-Grade 3
8.975000E-01
Grade 1-vs-Grade 4
3.454200E-01
Grade 2-vs-Grade 3
6.764000E-01
Grade 2-vs-Grade 4
5.891400E-01
Grade 3-vs-Grade 4
1.468580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.987500E-02
Normal-vs-NonDiabetic
8.523600E-02
Diabetic-vs-NonDiabetic
6.808400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.464400E-02
Normal-vs-NoPancreatitis
7.357600E-02
Pancreatitis-vs-NoPancreatitis
2.519600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.632500E-02
Normal-vs-N1
9.032100E-02
N0-vs-N1
6.821400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.726400E-01
Normal-vs-TP53-NonMutant
5.791200E-01
TP53-Mutant-vs-TP53-NonMutant
6.488600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
